163 related articles for article (PubMed ID: 37392249)
21. The predictive role of lung ultrasound in progression of scleroderma interstitial lung disease.
Gasperini ML; Gigante A; Iacolare A; Pellicano C; Lucci S; Rosato E
Clin Rheumatol; 2020 Jan; 39(1):119-123. PubMed ID: 31327084
[TBL] [Abstract][Full Text] [Related]
22. Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis.
Gonzalez-Lopez L; Rocha-Muñoz AD; Olivas-Flores EM; Garcia-Gonzalez A; Peguero-Gómez AR; Flores-Navarro J; Villa-Manzano AI; Zavaleta-Muñiz SA; Salazar-Paramo M; Mejía M; Juárez-Contreras P; Vazquez-Del Mercado M; Cardona-Muñoz EG; Trujillo-Hernández B; Nava-Zavala AH; Gamez-Nava JI
Arch Bronconeumol; 2015 Sep; 51(9):440-8. PubMed ID: 25301411
[TBL] [Abstract][Full Text] [Related]
23. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
[TBL] [Abstract][Full Text] [Related]
24. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
[TBL] [Abstract][Full Text] [Related]
25. CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis: Data From Two Independent Cohorts.
Wu M; Baron M; Pedroza C; Salazar GA; Ying J; Charles J; Agarwal SK; Hudson M; Pope J; Zhou X; Reveille JD; Fritzler MJ; Mayes MD; Assassi S
Arthritis Rheumatol; 2017 Sep; 69(9):1871-1878. PubMed ID: 28575534
[TBL] [Abstract][Full Text] [Related]
26. [Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms].
Zhu HL; DU Q; Chen WL; Zuo XX; Li QZ; Liu SJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):716-722. PubMed ID: 31420628
[TBL] [Abstract][Full Text] [Related]
27. Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease?
Hizal M; Bruni C; Romano E; Mazzotta C; Guiducci S; Bellando Randone S; Blagojevic J; Lepri G; Tufan A; Matucci Cerinic M
Clin Rheumatol; 2015 Apr; 34(4):795-8. PubMed ID: 25597616
[TBL] [Abstract][Full Text] [Related]
28. Relationship between interstitial lung disease and oesophageal dilatation on chest high-resolution computed tomography in patients with systemic sclerosis: a cross-sectional study.
Salaffi F; Di Carlo M; Carotti M; Fraticelli P; Gabrielli A; Giovagnoni A
Radiol Med; 2018 Sep; 123(9):655-663. PubMed ID: 29687210
[TBL] [Abstract][Full Text] [Related]
29. Interstitial lung disease in systemic sclerosis.
Ooi GC; Mok MY; Tsang KW; Wong Y; Khong PL; Fung PC; Chan S; Tse HF; Wong RW; Lam WK; Lau CS
Acta Radiol; 2003 May; 44(3):258-64. PubMed ID: 12751995
[TBL] [Abstract][Full Text] [Related]
30. Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis.
Hesselstrand R; Wildt M; Bozovic G; Andersson-Sjöland A; Andréasson K; Scheja A; Westergren-Thorsson G; Bjermer L; Wuttge DM
Respir Med; 2013 Jul; 107(7):1079-86. PubMed ID: 23660398
[TBL] [Abstract][Full Text] [Related]
31. Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.
Elhai M; Hoffmann-Vold AM; Avouac J; Pezet S; Cauvet A; Leblond A; Fretheim H; Garen T; Kuwana M; Molberg Ø; Allanore Y
Arthritis Rheumatol; 2019 Jun; 71(6):972-982. PubMed ID: 30624031
[TBL] [Abstract][Full Text] [Related]
32. Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndrome.
Pinal-Fernandez I; Pallisa-Nuñez E; Selva-O'Callaghan A; Castella-Fierro E; Simeon-Aznar CP; Fonollosa-Pla V; Vilardell-Tarres M
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S136-41. PubMed ID: 26315813
[TBL] [Abstract][Full Text] [Related]
33. Detection of interstitial lung disease in systemic sclerosis through partitioning of lung transfer for carbon monoxide.
Pernot J; Puzenat E; Magy-Bertrand N; Manzoni P; Gondouin A; Bourdin H; Simon-Rigaud ML; Regnard J; Degano B
Respiration; 2012; 84(6):461-8. PubMed ID: 22301769
[TBL] [Abstract][Full Text] [Related]
34. Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease.
Chung JH; Walker CM; Hobbs S
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32744514
[TBL] [Abstract][Full Text] [Related]
35. A comparative study of modulatory interaction between cytokines and apoptotic proteins among Scleroderma patients with and without pulmonary involvement.
Khadilkar P; Chougule D; Tipnis T; Khopkar U; Nadkar M; Rajadhyaksha A; Kini S; Kharkar V; Athvale A; Athvale T; Madkaikar M; Pradhan V
Cytokine; 2023 Jun; 166():156183. PubMed ID: 37011542
[TBL] [Abstract][Full Text] [Related]
36. Serum cytokines and their predictive value in pulmonary involvement of systemic sclerosis.
Becker MO; Radic M; Schmidt K; Huscher D; Riedlinger A; Michelfelder M; Meisel C; Ewert R; Burmester GR; Riemekasten G
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(4):274-284. PubMed ID: 32476963
[TBL] [Abstract][Full Text] [Related]
37. Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT.
Occhipinti M; Bruni C; Camiciottoli G; Bartolucci M; Bellando-Randone S; Bassetto A; Cuomo G; Giuggioli D; Ciardi G; Fabbrizzi A; Tomassetti S; Lavorini F; Pistolesi M; Colagrande S; Matucci-Cerinic M
Ann Rheum Dis; 2020 Sep; 79(9):1210-1217. PubMed ID: 32606043
[TBL] [Abstract][Full Text] [Related]
38. Underdetection of Interstitial Lung Disease in Juvenile Systemic Sclerosis.
Foeldvari I; Klotsche J; Hinrichs B; Helmus N; Kasapcopur O; Adrovic A; Sztajnbok F; Terreri MT; Anton J; Smith V; Katsicas M; Kostik M; Vasquez-Canizares N; Avcin T; Feldman B; Janarthanan M; Santos MJ; Sawhney S; Schonenberg-Meinema D; Sifuentes-Giraldo WA; Alexeeva E; Appenzeller S; Battagliotti C; Berntson L; Bica B; Costa-Reis P; Eleftheriou D; Kallinich T; Lehman T; Marrani E; Minden K; Nielsen S; Nuruzzaman F; Patwardhan A; Khubchandani R; Stanevicha V; Uziel Y; Torok KS
Arthritis Care Res (Hoboken); 2022 Mar; 74(3):364-370. PubMed ID: 33141441
[TBL] [Abstract][Full Text] [Related]
39. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
[TBL] [Abstract][Full Text] [Related]
40. Evolution of high-resolution CT-scan in systemic sclerosis-associated interstitial lung disease: Description and prognosis factors.
Forestier A; Le Gouellec N; Béhal H; Kramer G; Perez T; Sobanski V; Dubois SM; Lambert M; Hatron PY; Hachulla E; Duhamel A; Matran R; Launay D; Rémy-Jardin M
Semin Arthritis Rheum; 2020 Dec; 50(6):1406-1413. PubMed ID: 32245698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
